ACE Inhibitor-Induced Cough: Onset Timing
ACE inhibitor-induced cough can begin anywhere from within hours of the first dose to several weeks or months after starting therapy, with most cases developing within the first 4 weeks of treatment. 1
Timing of Onset
The onset window for ACE inhibitor-induced cough is highly variable:
- Earliest onset: Within hours of the first dose
- Most common timeframe: Within the first week to 4 weeks of therapy 2, 3
- Delayed onset: Can occur weeks to months after initiation 1
This wide variability is a critical clinical point—you cannot rule out ACE inhibitor-induced cough based on temporal relationship alone. The ACCP evidence-based guidelines explicitly state that ACE inhibitors should be considered causative "regardless of the temporal relation between the initiation of ACE inhibitor therapy and the onset of cough." 1
Clinical Characteristics
The cough is characteristically:
- Dry and nonproductive in all cases
- Associated with a tickling or scratching throat sensation 1
- Persistent throughout therapy
- Worse at night (reported by 79.4% of patients) 2
Key Clinical Pitfall
The most important caveat is that ACE inhibitors may sensitize the cough reflex, thereby potentiating other causes of chronic cough 1. This means a patient may develop cough from another etiology that is amplified by concurrent ACE inhibitor use, even if the ACE inhibitor has been taken for months without issue.
Resolution Timeline
When you discontinue the ACE inhibitor:
- Typical resolution: 1-4 weeks after cessation 1
- Delayed resolution: Up to 3 months in a subgroup of patients 1
- Average resolution: Approximately 6 days (range: typically ≤10 days for 96.7% of patients) 4
Risk Factors for Development
Higher risk populations include:
- Women (37.9% vs 15.5% in men) 2, 4
- Nonsmokers 1
- Persons of Chinese origin 1
- Patients with obstructive sleep apnea 4
- Concomitant thiazide use 4
Protective factor: Statin use (OR 0.69) 4
Practical Management Algorithm
If cough develops at any time during ACE inhibitor therapy: Continue for a few days to exclude acute viral infection 5
If cough persists >1 week: Initiate diagnostic workup for other pulmonary causes while considering ACE inhibitor as causative
To confirm diagnosis: Discontinue ACE inhibitor and observe for resolution within 1-4 weeks (up to 3 months in some cases) 1
Important exception: Some patients (approximately 30%) will not redevelop cough upon rechallenge, so a repeat trial may be attempted if there is compelling reason to use ACE inhibitor therapy 1
The incidence of this side effect ranges from 5-35% in treated patients, though it's responsible for only 0-3% of chronic cough cases presenting for evaluation 1. The cough is not dose-dependent 1, so dose reduction is unlikely to help.